PDL BioPharma, Inc. (PDLI) financial statements (2021 and earlier)

Company profile

Business Address 932 SOUTHWOOD BLVD
INCLINE VILLAGE, NV 89451
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments193395532242220294100
Cash and cash equivalents19339552714721929194
Short-term investments  595125
Receivables66858515158580
Inventory, net of allowances, customer advances and progress billings401993  
Inventory401993   
Prepaid expense      2
Deferred costs      3
Derivative instruments and hedges, assets    33 
Deferred tax assets   100
Other current assets      2
Other undisclosed current assets151914201 
Total current assets:314517640398283356108
Noncurrent Assets
Property, plant and equipment6770000
Long-term investments and receivables1194235307306194
Long-term investments  7575   
Accounts and financing receivable, after allowance for credit loss1119160307306194
Intangible assets, net (including goodwill)2351216229  471
Intangible assets, net (excluding goodwill)2351216229  471
Derivative instruments and hedges     1 
Other noncurrent assets249117128 
Other undisclosed noncurrent assets348378275347415292(229)
Total noncurrent assets:402447603817733606436
TOTAL ASSETS:7169641,2431,2151,016962544
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities46526742122013
Accounts payable1713207000
Accrued liabilities283946318912
Employee-related liabilities     11
Taxes payable001533 
Interest and dividends payable     6 
Debt  126 25175395
Derivative instruments and hedges, liabilities      7
Other undisclosed current liabilities   88 (8)(8)
Total current liabilities:465219313037188407
Noncurrent Liabilities
Long-term debt and lease obligation27125117232233276 
Long-term debt, excluding current maturities27125117232233276 
Liabilities, other than long-term debt50578797517535
Accounts payable and accrued liabilities     11 
Deferred compensation liability, classified     1 
Liability for uncertainty in income taxes     2611
Other liabilities50574555513823
Business combination, contingent consideration, liability  4243  
Derivative instruments and hedges, liabilities      2
Other undisclosed noncurrent liabilities     (38)(12)
Total noncurrent liabilities:7718120433028331423
Total liabilities:123234397460320502430
Stockholders' equity
Stockholders' equity attributable to parent593730846751696460113
Common stock1122221
Treasury stock, value (2)     
Additional paid in capital(79)(98)(102)(108)(118)(120)(233)
Accumulated other comprehensive income (loss)  1 23(5)
Retained earnings671829946857810576350
Stockholders' equity attributable to noncontrolling interest0  4   
Total stockholders' equity:593730846755696460113
TOTAL LIABILITIES AND EQUITY:7169641,2431,2151,016962544

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues55198320244590581443
Revenue, net1043211443
Cost of revenue(54)(48)(31)(4)  (6)
Cost of goods and services sold(6)(15)(27)(12)   
Gross profit:1150290240590581437
Operating expenses(155)(249)(126)(115)(40)(35)(35)
Other undisclosed operating income5448314  6
Operating income (loss):(100)(51)194129550546408
Nonoperating income (expense)26(5)(9)(20)(20)(45)(6)
Investment income, nonoperating671110019
Interest and debt expense(8)(12)(20)(2)6(45)(25)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes812202(6)4525
Income (loss) from continuing operations before income taxes:(74)(56)185109530501402
Income tax expense (benefit)3(13)(74)(46)(197)(179)(137)
Net income (loss):(71)(69)11164333322265
Other undisclosed net income (loss) attributable to parent0 0(0)   
Net income (loss) available to common stockholders, basic:(70)(69)11164333322265
Interest on convertible debt      0
Net income (loss) available to common stockholders, diluted:(70)(69)11164333322265

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income (loss):(71)(69)11164333322265
Other comprehensive income (loss) (1)1(2)(1)80
Comprehensive income (loss):(71)(70)11261332330265
Comprehensive income (loss), net of tax, attributable to noncontrolling interest0 0(0)   
Comprehensive income (loss), net of tax, attributable to parent:(70)(70)11261332330265

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: